Related Experiment Videos

Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissues from nude

A Johnsson1, C Olsson, H Anderson

  • 1Department of Oncology, University Hospital, Lund, Sweden.

Cytometry
|October 1, 1994
PubMed

Insights

This study validated an immunohistochemical method for quantifying cisplatin (CDDP) in mouse tissues. The method is reliable for comparing CDDP-DNA adducts within specific experimental conditions, aiding cancer drug research.

Area of Science:

  • Pharmacology
  • Oncology
  • Biochemistry

Background:

  • Cisplatin (CDDP) is a crucial chemotherapy drug.
  • Accurate measurement of CDDP-DNA adducts is vital for understanding its efficacy and toxicity.
  • Existing methods for visualizing CDDP-DNA adducts have limitations.

Purpose of the Study:

  • To investigate the reproducibility of an immunohistochemical method for visualizing and quantifying cisplatin (CDDP) bound to nuclear DNA.
  • To assess the feasibility of this method for analyzing CDDP in kidney, liver, and tumor tissues.
  • To determine the method's utility in drug development and personalized medicine.

Main Methods:

  • Immunohistochemistry using a Peroxidase-Antiperoxidase (PAP) technique.
  • An antiserum specifically targeting CDDP-DNA adducts was employed.
  • Quantification of the nuclear precipitate was performed using a CAS 200 image analyzer.
  • Estimation of variance components for staining and image analysis errors.

Main Results:

  • The immunohistochemical method demonstrated feasibility for CDDP-DNA adduct visualization and quantitation.
  • Reproducibility was confirmed for comparisons within the same tissue type, staining batch, and observer.
  • The method is suitable for analyzing cisplatin in kidney, liver, and tumor tissues from treated nude mice.

Conclusions:

  • The developed immunohistochemical method is a valuable tool for studying cisplatin pharmacodynamics.
  • It can aid in predicting patient sensitivity to cisplatin-based chemotherapy.
  • The method supports research on drug interactions involving cisplatin and other chemomodulators.

Related Concept Videos